These reports partly corroborate our suggestion, thus we also conclude that the downregulation of Serpinf1 gene expression in fibroblasts and fibromyocytes results in a shortage of PEDF, which aggravate the development of atherosclerosis and accelerate the formation of plaques. The gene discussed is SERPINF1; the disease is atherosclerosis.